CVR: 24257924
Secondary names: NOVO PHARMACEUTICALS A/S, NOVO FARMAKA A/S, NOVO NORDISK FARMAKA DANMARK A/S
Previous names: NOVO FARMAKA A/S
Selskabtes formål er at drive fremstilling af og handel med lægemidler og dermed beslægtede produkter og anden dermed i forbindelse stående virksomhed, herunder forskning og investering.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | - | 2.1 mio. | 30.5 mio. | 12.3 mio. | 0 | |
Compared to 20.830 companies in Anden finansiel formidling i.a.n.
Comparison is based on industry median values
Anders Rytter Mikkelsen joined as director
Peter Bøggild left as director
Naja Eilers Barrisøe joined the board
Karsten Munk Knudsen left the board
Companies in the same industry and area
CVR 21244643
CVR 43221124
CVR 36951982
CVR 34055467
CVR 16257281
companydata.dk